G Medical Innovations Holdings Ltd
GMVD · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.05 | -0.00 | 1.32 |
| FCF Yield | 0.00% | -63.51% | -20.32% | -0.11% |
| EV / EBITDA | -0.05 | -2.30 | -3.33 | -31.22 |
| Quality | ||||
| ROIC | 1,106.96% | -199.50% | 12,617.89% | -1,870.27% |
| Gross Margin | 17.74% | 29.70% | 13.61% | -4.04% |
| Cash Conversion Ratio | 0.74 | 0.77 | 0.37 | – |
| Growth | ||||
| Revenue 3-Year CAGR | -3.38% | -2.91% | 16.97% | 270.11% |
| Free Cash Flow Growth | -71.04% | -133.68% | -1,101.40% | 97.59% |
| Safety | ||||
| Net Debt / EBITDA | -0.05 | -0.20 | -0.31 | -0.79 |
| Interest Coverage | 0.00 | -2.23 | -16.01 | -3.78 |
| Efficiency | ||||
| Inventory Turnover | 12.45 | 10.02 | 47.03 | 15.21 |
| Cash Conversion Cycle | -360.03 | -131.85 | -247.14 | -102.88 |